Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan
Journal of Peptide Science · 2023
DOI: 10.1002/psc.3493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, 2023. Verfasst von Areti Gkika und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Patras, Rion Patras, Greece. Hauptthemen laut MEDLINE: Immunodominant Epitopes, Myelin-Oligodendrocyte Glycoprotein, Peptide Fragments, Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Operational Program Competitiveness, Entrepreneurship and Innovation.
Abstract (Originalsprache)
Analogs of immunodominant myelin peptides involved in multiple sclerosis (MS: the most common autoimmune disease) have been extensively used to modify the immune response over the progression of the disease. The immunodominant 35–55 epitope of myelin oligodendrocyte glycoprotein (MOG 35–55 ) is an autoantigen appearing in MS and stimulates the encephalitogenic T cells, whereas mannan polysaccharide ( Saccharomyces cerevisiae ) is a carrier toward the mannose receptor of dendritic cells and macrophages. The conjugate of mannan‐MOG 35–55 has been extensively studied for the inhibition of chronic experimental autoimmune encephalomyelitis (EAE: an animal model of MS) by inducing antigen‐specific immune tolerance against the clinical symptoms of EAE in mice. Moreover, it presents a promising approach for the immunotherapy of MS under clinical investigation. In this study, a competitive enzyme‐linked immunosorbent assay (ELISA) was developed to detect the MOG 35–55 peptide that is conjugated to mannan. Intra‐ and inter ‐day assay experiments proved that the proposed ELISA methodology is accurate and reliable and could be used in the following applications: (i) to identify the peptide (antigen) while it is conjugated to mannan and (ii) to adequately address the alterations that the MOG 35–55 peptide may undergo when it is bound to mannan during production and stability studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Patras, Rion Patras, Greece.
- Vianex S.A., Nea Erythrea, Greece.
ORCID-Profile: Theodore Tselios
Förderung
- Operational Program Competitiveness, Entrepreneurship and Innovation
Zitieren
APA
Gkika, A., Androutsou, M. E., Aletras, A. J., & Tselios, T. (2023). Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan. Journal of Peptide Science. https://doi.org/10.1002/psc.3493
Vancouver
Gkika A, Androutsou ME, Aletras AJ, Tselios T. Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan. Journal of Peptide Science. 2023. doi:10.1002/psc.3493
BibTeX
@article{Gkika2023,
author = {Gkika, Areti and Androutsou, Maria-Eleni and Aletras, Alexios J and Tselios, Theodore},
title = {Competitive ELISA for the identification of 35–55 myelin oligodendrocyte glycoprotein immunodominant epitope conjugated with mannan},
journal = {Journal of Peptide Science},
year = {2023},
doi = {10.1002/psc.3493}
}
EUVIMED